Antimicrobial activity of N-hydroxyalkyl 1,2-benzisothiazol-3(2H)-ones and their thiono analogues

European Journal of Medicinal Chemistry

Volumn 31, Issue 11, 1996, Pages 919-925

  Borgna, P ^a   Carmellino, M L ^a   Natangelo, M ^b   Pagani, G ^a   Pastoni, F ^c   Pregnolato, M ^a   Terreni, M ^a  

^a UNIVERSITY OF PAVIA   (Italy)

^b MARIO NEGRI INSTITUTE FOR PHARMACOLOGICAL RESEARCH   (Italy)

^c JOINT RESEARCH CENTRE   (Italy)

Author keywords

1,2 Benzisothiazol 3(2H) one; 1,2 Benzisothiazol 3(2H) thione; Antibacterial activity; Antifungal activity

Indexed keywords

1,2 BENZISOTHIAZOLE DERIVATIVE; CEFOTAXIME; COTRIMOXAZOLE; GENTAMICIN;

ANTIBACTERIAL ACTIVITY; ANTIFUNGAL ACTIVITY; ARTICLE; CLOSTRIDIUM PERFRINGENS; DRUG STRUCTURE; DRUG SYNTHESIS; GRAM POSITIVE BACTERIUM; IN VITRO STUDY; LIPOPHILICITY; MASS SPECTROMETRY; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; STRUCTURE ACTIVITY RELATION;

EID: 0029851193     PISSN: 02235234     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0223-5234(97)89857-1     Document Type: Article

References (28)

1. 1 De A (1981) Progress in Medicinal Chemistry (Ellis GP, West GB, eds) Elsevier/North-Holland Biomedical Press, vol 18, 117-133
2. 2 Davis M (1972) Advances in Heterocyclic Chemistry (Katritzky AR, Boulton AJ, eds) Academic Press, New York, vol 14, 58-63
3. 3 Davis M (1985) Advances in Heterocyclic Chemistry (Katritzky AR, Boulton AJ, eds) Academic Press, New York, vol 38, 114-116
4. 4 Andrykovitch G, Neihof RA (1987) J Indust Microbiol 2, 35-40
5. 5 Andersen KE, Hamann K (1984) Fd Chem Toxic 22, 655-660
6. 6 Ponci R, Vitali T, Mossini F, Amoretti L (1967) Il Farmaco Ed Sc 22, 999-1010
7. 7 Baruffini A, Borgna P, Gialdi F, Ponci R (1968) Farmaco Ed Sci 23, 3-15
8. 8 Montecatini Edison Spa (1969) Italian Patent 800,015; Chem Abstr 70, 37807
9. Montecatini Edison Spa (1969) Italian Patent 800,015; Chem Abstr 70, 37807
10. 9 Borgna P, Vicarini L, Carmellino ML, Pagani G (1983) Il Farmaco Ed Sci 38, 801-810
11. 10 Carmellino ML, Pagani G, Pregnolato M, Terreni M, Pastoni F (1994) Eur J Med Chem 29, 743-751
12. 11 Labbe R (1989) In: Foodborne Bacterial Pathogens (Doyle M, ed) Marcel Dekker, New York, 191-215
13. 12 McClelland EW, Gait AJ (1926) J Chem Soc 921-925
14. 13 McClelland EW, Warren LA, Jackson JH (1929) J Chem Soc 1582-1588
15. 14 McClelland EW, Salkeld CE (1936) J Chem Soc 1143-1148
16. 15 Böshagen H, Feltkamp H, Geiger W (1967) Chem Ber 100, 2435-2444
17. 16 Baruffini A, Borgna P, Amoretti L (1968) Il Farmaco Ed Sci 23, 572-582
18. 17 Borgna P, Amoretti L, Gaetani A (1968) Il Farmaco Ed Sci 23, 1193-1212
19. 18 Borgna P, Pregnolato M, Gamba IA, Mellerio G (1993) J Heterocycl Chem 30, 1079-1084
20. 19 Pregnolato M, Borgna P, Terreni M (1995) J Heterocycl Chem 32, 847-850
21. 20 Scheibye S, Pedersen BS, Lawesson SO (1978) Bull Soc Chim Belg 87, 229-238
22. 21 Fuller SJ, Denyer SP, Hugo WB, Pemberton D, Woodcock PM, Buckley AJ (1985) Lett Appl Microbiol 1, 13-15
23. 22 Borgna P, Pregnolato M, Gamba AI, Mellerio G (1993) J Heterocycl Chem 30, 1079-1084
24. 23 Boyce CBC, Milborrow BV (1965) Nature 208, 537-539
25. 24 Tomlison E (1975) J Chromatogr 113, 1-45
26. 25 Biagi GL, Recanatini M, Barbaro AM et al (1991) QSAR: Rational Approaches to the Design of Bioactive Compounds (Silipo C, Vittoria A, eds) Elsevier, Amsterdam, vol 16, 83-90
27. 26 Dross KP, Mannhold R, Rekker RF (1992) Quant Struct-Act Relat 11, 36-44
28. 27 Fisher R, Hürni H (1964) Arzneimittel-Forsch 14, 1301-1306